(Bloomberg) -- Thai households can now grow six pots of cannabis each to supplement their income, the nation’s health minister said, as the first country in the region to legalize medical marijuana further eased rules to promote the crop’s commercial use.Families may form communities to grow marijuana and supply the crop to public hospitals and state facilities, or use them to make food and cosmetic products as a fresh revenue source, Thailand’s Deputy Premier and Health Minister Anutin Charnvirakul said in a statement Friday.“Marijuana and hemp are both economic crops and it provides a new option for locals to generate revenue,” Anutin said at a marijuana educational expo at Buriram, 400 kilometers northeast of Bangkok. “We are trying to ease restrictions to allow the public easier access to the plant, but please cooperate and use it correctly.”While Thailand became the first country in Southeast Asia to legalize medical marijuana in 2018, its use for recreational purpose is still banned. Any flowers and seeds yielded from the crop grown at homes must be sent to state medical facilities as they remain in the country’s criminal code due to their high levels of psychoactive compounds, the minister said.The rest of the marijuana, including leaves, branches and fiber as well as hemp plants have been decriminalized and allowed to be used in food and cosmetic products since December last year. Anutin became a minister in 2019 after an election in which the centerpiece of his political party’s campaign was marijuana legalization.Though some restrictions remain, allowing households to grow marijuana is another step to unshackle the industry and is similar to Sri Lanka which allows limited growth of the plant by state-licensed growers and only for medical purposes. The Philippines is considering allowing use of the plant for epilepsy treatment, but marijuana in most other nations in Southeast Asia remains forbidden and in some, punishable with death sentences.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Canopy Growth Corp. will deepen its U.S. presence by launching four sparkling cannabidiol waters there before possible federal legalization. The Smiths Falls, Ont.-based cannabis company said four drinks from its Quatreau brand will be available online to U.S. customers Tuesday. They will contain 20 milligrams of CBD, come in ginger and lime, cucumber and mint, blueberry and açaí, and passion fruit and guava flavours and be Canopy’s first CBD drinks to cross the border. The beverages, which have been available in Canada since last fall, will join Martha Stewart, BioSteel and This Works CBD products Canopy already sells in the U.S. as part of an expansion strategy. “When we look at opportunities on a global basis, Canadians and Americans have a lot of the same consumer insights … but there's no doubt that the United States is a larger population, and therefore a larger business opportunity,” said Rade Kovacevic, Canopy's president and chief product officer. Industry observers believe those U.S. opportunities will multiply this year because U.S. President Joe Biden and his Democratic party have favoured legislation to relax cannabis laws. Biden supports decriminalizing pot, expunging criminal records related to its possession and the Safe Banking Act, a Democratic bill that would allow financial institutions to work with cannabis companies without retribution. Ahead of his inauguration, the U.S. House of Representatives paved the way for federal cannabis legalization by voting in favour of taking the substance off the dangerous drugs list, but Senate and White House approvals are needed for the policy to be implemented. Some believe those approvals could come this year. Canopy is preparing for that day by pushing into the market first with CBD, a compound found in cannabis and hemp that doesn’t produce a high but is believed to relax consumers. CBD regulations vary across states, but several have approved its recreational use and many more have OK'd it on a medical basis. Meanwhile, consumer demand for CBD is growing. New Frontier Data and Square predict US$121 billion will be spent on CBD across the country between 2020 and 2025, with consumers between the ages of 34 and 44 fuelling much of the boom. Canopy’s research also revealed that while most Americans have heard of CBD, two out of every three can’t name more than one brand producing it. “Market share is highly fragmented and so for us, this plays very much to our strengths of having a proven brand with a proven formulation that we know how to scale for a large number of consumers,” Kovacevic said. When choosing to introduce Quatreau to the U.S., Canopy first turned to consumer insights to discover what Canada’s neighbours like, he said. “Someone in Rochester, N.Y. is more likely to have similar taste profiles to someone in Toronto, than someone in Dallas, Texas, for example,” he said. Once Canopy identified tastes and overlaps between its Quatreau products, it took on production, logistics, supply chain, distribution and marketing. The Quatreau sparkling waters will be sold through e-commerce — a model that can be built on if the U.S. cannabis market flourishes, Kovacevic said. “That way as the opportunity in the United States continues to open up and scale, we're going to be positioned to be able to consolidate consumers interest in our products and brands and continue to drive them forward.” This report by The Canadian Press was first published March 2, 2021. Companies in this story: (TSX: WEED) Tara Deschamps, The Canadian Press
David Beckham owns 5% of cannabinoid skincare company Cellular Goods through his holding company DB Ventures.